This is great news. Will keep my position until Q3 2022 to see how china's results pan.
Great price to collect more with high ceilings in the short to meduim term
- Forums
- ASX - By Stock
- Ann: Brain Injury Program Target Unveiled and Phase I Update
NYR
nyrada inc.
Add to My Watchlist
9.62%
!
23.5¢

This is great news. Will keep my position until Q3 2022 to see...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.5¢ |
Change
-0.025(9.62%) |
Mkt cap ! $49.56M |
Open | High | Low | Value | Volume |
26.0¢ | 26.0¢ | 23.5¢ | $89.53K | 372.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23000 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 23000 | 0.230 |
1 | 100000 | 0.225 |
3 | 71773 | 0.220 |
2 | 120005 | 0.215 |
6 | 179378 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 30000 | 1 |
0.240 | 140000 | 1 |
0.250 | 260000 | 2 |
0.260 | 129498 | 3 |
0.270 | 140000 | 2 |
Last trade - 11.26am 19/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online